An understanding of developmental biology can provide useful insights into how different tissueengineered repairs might be designed. During embryogenesis of the intervertebral disk, the cells of the notochord play a critical role in initiating tissue formation, and may be responsible for development of the nucleus pulposus. In some species, including humans, these notochordal cells may eventually be lost, either through apoptosis or terminal differentiation, and are replaced by chondrocyte-like cells. However, there is some evidence that the notochordal cells may persist in at least some humans. This review discusses some of the potential applications of notochordal cells in tissue engineering of the nucleus pulposus.
INTRODUCTION T
HE INTERVERTEBRAL DISKS (IVDs) join adjacent vertebral bodies, providing flexibility and integrity to the spine. Each disk consists of three major regions: an outer anulus fibrosus consisting of concentric lamellae of collagen fibers; superior and inferior cartilaginous end plates, which mark the transition between the IVD and the vertebra; and an inner, soft, and highly hydrated nucleus pulposus 1 (Fig. 1) . The nucleus pulposus is critical to disk function and health, and disk disease often originates there. 2, 3 The cells within the nucleus pulposus, which are responsible for synthesizing and maintaining the tissue, are the subject of this review.
The extracellular matrix of the nucleus pulposus is composed largely of water, collagen type II, and aggrecan, a large aggregating proteoglycan. These molecules are also characteristic of articular cartilage, but the proportions and organization are different in the nucleus, resulting in a tissue with distinctly different mechanical properties (whereas cartilage behaves largely like a viscoelastic solid, nucleus pulposus can behave both as a fluid and as a viscoelastic solid under different loading conditions 4 ). Minor constituents include collagen types IX, VI, and III 5 and small proteoglycans such as decorin, biglycan, lumican, and fibromodulin. 6, 7 The cells of the mature human nucleus are primarily small chondrocytelike cells, but in young individuals and in adults of certain species, there is a second population of large cells with granular cytoplasmic inclusions. These are the "notochordal" cells-presumed remnants of the embryonic tissue that guided formation of the spine and the nuclei pulposi. 8, 9 Because these cells appear to play an important role in formation of the spine, it might be hypothesized that they could influence repair of the damaged disk.
Disorders of the lower back have a high impact on industrialized society, both physically through the morbidity of afflicted individuals, and financially through lost productivity and increased health care costs. 10, 11 Low back pain is the most common cause of musculoskeletal impairment. 12 In the United States, direct medical plus indirect costs for low back pain have been estimated to be $50-100 billion per annum. 12, 13 Statistics indicate that back pain resulted in an annual average of 297 million restricted activity days in the United States from 1992 to 1994. 14 Chronic pain is of most concern from an afflicted individual and financial viewpoint; while those individuals with chronic disability form the minority of the population (25%), they incur the majority of compensation costs (90%). 12, 13 Low back pain is commonly believed to result from degeneration of the intervertebral disk, either through herniation of disk material into the vertebral foramen, where it affects the spinal cord, or through disk height reduction, which collapses the vertebral facets and compresses the nerve roots. 3, 15 In a normal, healthy disk, the axial loads applied to the spine induce hydrostatic pressure in the nucleus pulposus, which is constrained by cir-cumferential stress in the anulus fibrosus. 16 As the disk degenerates, the composition and structure of the nucleus undergo changes that result in alteration in the mechanical function of the disk, and can ultimately lead to failure of the tissue. Disk degeneration is often first noted in the nucleus as changes in the proteoglycan content. 2, 3 These proteoglycans enable the nucleus to retain water, 2,17 thereby cushioning and absorbing the considerable loads placed on the tissue. Consequent to these changes, the mechanical loading in the disk is altered over time (the loss of hydrostatic pressure in the nucleus causes the inner anulus fibrosus to collapse inward) 18, 19 (Fig. 2) . The nucleus eventually becomes more fibrous (Fig. 3) , and the peripheral anulus fibrosus is forced to carry larger loads, leading to tears, bulging, rupture, and herniation (i.e., a slipped disk). 20 This paradigm has been explored specifically in various animal models, wherein static compression of disks caused degenerative changes in the disk. 21, 22 The primary current treatment for painful disk degeneration is surgical removal of disk material to alleviate impingement on spinal nerve roots. In severe cases in which the spine is mechanically unstable, fusion and internal fixation can be performed to stabilize the adjacent vertebrae. 23, 24 Although spinal fusion is beneficial in some cases-particularly when disk herniation is clearly the primary cause of pain-the general success rate ranges from 50 to 75% for all fusions performed. 25, 26 There is a clear need for more effective early treatment and diagnosis of disk degeneration before herniation. One potential treatment option is to repair or replace the intervertebral disk before pronounced disk space narrowing and nerve root impingement occur, thereby delaying or even preventing the need for spinal fusion.
Tissue engineering aims to use "living cells, manipulated through their extracellular environment or even genetically, to develop biological substitutes for implantation into the body and/or to foster the remodeling of tissue in some other active manner. The purpose is to either repair, replace, maintain, or enhance the function of a particular tissue or organ." 27 Thus, an attempt to tissue engineer the nucleus pulposus-and eventually the entire disk-might involve directly replacing the diseased tissue or fostering self-regeneration. However, before a tissue-engineered disk can be developed, it is necessary to identify useful cell populations either capable of synthesizing the new disk tissue directly, or coordinating the activity of other cell types to regenerate the disk.
THE NOTOCHORDAL CELL*: DEFINITION AND NATURAL HISTORY
During embryonic development, the growing cell mass begins to differentiate into regions with different destinies. The trilaminar disk phase occurs about day 15 of embryonic development in humans, and consists of three germ layers: the endoderm, mesoderm, and ectoderm. These layers ultimately give rise to the internal organs, NOTOCHORDAL CELL IN NUCLEUS PULPOSUS the musculoskeletal tissues, and the epidermal and nervous tissues, respectively. Whereas these three layers give rise to most of the adult organism, a fourth region forms that is destined to give rise to only one structure. This "prototissue" forms at the center of the embryo, and appears as a rod of tissue known as the notochord, which guides the embryonic development of the neural tube and the vertebral column, including the intervertebral disks. [28] [29] [30] [31] Around day 20 of embryonic development in humans, the ectoderm folds in on itself over the notochord to form the neural tube, which eventually gives rise to the spinal cord and brain. Around day 30, mesenchymal cells begin to migrate and condense around the notochord to form the vertebrae and anulus fibrosus. 28 The exact role of the entrapped notochordal cells after condensation is unclear, but they are believed to take part in formation of the nucleus pulposus. 30, 32 In some vertebrates, the notochordal cells persist through most of adult life, whereas in other species, the notochordal cells gradually disappear during maturation, eventually becoming undetectable in the nuclei pulposi (Table 1) . 33, 34 It is presently unclear whether this disappearance is due to the terminal differentiation of the notochordal cells into cells with a chondrocytic phenotype, to programmed cell death, or to some other process. Interestingly, intervertebral disk degeneration can first be observed in the nucleus pulposus shortly after this time, although peak incidence in humans occurs much later in life (Table 1) . 10, 35, 36 The possible connection between loss of notochordal cells and disk disease is an intriguing possibility, deserving further consideration.
Historically, notochordal cells are distinguished from their chondrocyte-like neighbors by morphology. Notochordal cells exhibit distinct morphologies and intracellular organization when compared with the chondrocytic cells of the nucleus pulposus. The notochordal cells are larger (approximately 25-85 mm as opposed to 17-23 mm for chondrocytes 37 ), and contain "immature" mitochondria associated with rough endoplasmic reticulum, densely packed intracytoplasmic glycogen, and cytoplasmic filaments. 8, 9 The cells are generally termed "physaliferous" (bubble or vacuole containing) because of their unusual appearance; the cells contain large cytoplasmic inclusions that are surrounded by fibrous material (Fig. 4) . The exact functional significance of these various structures is unclear, but they are suggestive. For example, immature mitochondria suggest predominantly anaerobic metabolism, and their proximity to rough endoplasmic reticulum suggests that a substantial portion of the metabolic energy of the cells is being used for protein synthesis. Given the relatively low nutrient supply in the nucleus pulposus, the glycogen stores may function to supplement the nutritional supply during skeletal development. This might offer an explanation for the disappearance of notochordal cells in adulthood, as the en-ergy stores become depleted and the cells may literally starve to death.
More recently, molecular and immunological studies have demonstrated further differences between notochordal and chondrocytic cells. Notochordal cells express CD44s, 34 43 and HUNTER ET AL. collagen type IIA. [44] [45] [46] [47] [48] The first five molecules on this list are cytoplasmic or plasma membrane related, whereas the last two are extracellular matrix proteins. CD44s is a ubiquitous transmembrane glycoprotein that can bind to hyaluronan, 49 which in turn binds to the large proteoglycan aggrecan, 50, 51 and together they form a vast hydrated proteoglycan network. Galectin 3 is a soluble b- galactoside-binding protein that can bind to various cellassociated proteins, including integrins, 52 laminin, fibronectin, 53, 54 and tenascin. 55 Galectin 3 also functions to regulate mRNA splicing in the cytoplasm, 56 and may regulate endocytosis. 57 Vimentin and the cytokeratins are intermediate filament proteins that form the cytoskeleton. Intermediate filaments are most prominent in cells subjected to or producing mechanical stresses. [58] [59] [60] In the notochordal cell, these filaments may function to pull on the extracellular matrix and organize the tissue, or to withstand the hydrostatic pressures generated within the nucleus pulposus. The notochordal cells may use these various proteins to organize and coordinate the formation of the extracellular matrix during embryogenesis. 60 The two extracellular matrix (ECM) proteins listed above-CSPG and collagen IIA-are specialized subforms of more common ECM components. CSPG and the cartilage proteoglycan aggrecan are derived from the same gene, but undergo different posttranslational modifications. Most notably, whereas both core proteins contain keratan sulfate-binding regions, CSPG is devoid of keratan sulfate. The exact function of CSPG is unknown, but it has been suggested that it may function to direct chondrogenesis around the notochord. 61 Collagen type II is a fibrillar extracellular matrix protein found primarily in articular cartilage, the vitreous humor, and the nucleus pulposus. The predominant isoform in the body is the type "IIB" collagen, formed from exons 1 and 3-54. However, an alternate isoform exists, formed from exons 1 through 54. This type "IIA" isoform is expressed by chondroprogenitor tissues, including those associated with articular and tracheal cartilage, 44 nuclei pulposi, 48 and the notochord. 45 The region produced by exon 2 is rich in cysteine, and has some capacity to bind growth factors, including transforming growth factor b (TGF-b) and bone morphogenetic protein 2 (BMP-2). 62 The exon 2-encoded region of collagen IIA may therefore act as a "molecular concentrator" for growth factors during early development, thereby limiting their diffusion and amplifying their signals to encourage tissue formation.
670
Taken together, expression of these various proteins and corresponding genes partly defines the notochordal cell phenotype. However, it is largely a descriptive definition rather than a functional one, as it identifies some genes and proteins that are expressed by notochordal cells, but does not identify the particular functions that the cell serves. A functional definition will be necessary to achieve several research aims related to cell behavior during tissue formation, maintenance, and repair. For example, an improved understanding of the in vitro behavior of notochordal cells will facilitate a determination of how best to expand the cells for experimental or therapeutic applications. Retention of phenotype will also be important in tracking the migration, death, or differentiation of these cells during aging, disease, and repair processes. Indeed, isolation and purification of notochordal cells will also require the identification of distinct cell markers. Without such tools, further studies into the de- velopmental and therapeutic potential of notochordal cells will be severely limited. Therefore a major research goal should be to determine a functional phenotype for the notochordal cells, that is, what does the cell do during tissue formation and maintenance, and which genes and proteins are essential to those functions?
POTENTIAL FUNCTIONS OF THE NOTOCHORDAL CELL
Developmental studies have revealed that the notochord plays an essential role in forming the spinal column, including the intervertebral disks. However, the exact role that notochordal cells play in forming the nucleus pulposus is still largely unknown. Some authors have suggested that these cells directly synthesize the nucleus and differentiate into a chondrocytic cell type. 30, 63 Others have suggested that the nucleus is instead synthesized by cells that migrate from the surrounding mesenchyme, and that the notochordal cells direct cell migration and matrix synthesis and then undergo necrosis or apoptosis once disk formation is complete. 9,32,37,64 These two models indicate different functions for the notochordal cell: either as a stem cell or as an organizer cell for the nucleus pulposus.
Stem cells have received considerable attention in both the lay and professional media. There are two general classifications of stem cells, with different scientific and ethical implications: embryonic and adult. Embryonic stem cells are undifferentiated, multipotent cells obtained from embryos that have the potential to differentiate into any adult cell type. However, the ethical and moral complications involved in isolating and using embryonic stem cells will certainly delay and may completely prevent significant scientific progress with these potent cells. In contrast, adult stem cells are partially differentiated, multipotent cells taken from adult tissues, vestiges of the cells that gave rise to the adult tissues wherein they reside. These adult stem cells have more limited potential because they are partially differentiated, but the ethical concerns are less contentious than with embryonic stem cells because they can be harvested from adult tissues. These multipotent cells are thought to be capable of differentiating into a number of cell types and of synthesizing various tissues. Thus, they offer considerable therapeutic potential for initiating tissue regeneration or producing artificial transplantable organs; diseases with few treatment options today might someday be treated by selecting and manipulating the appropriate stem cells. Several types of adult stem cells have already been identified as capable of producing a wide range of cells and tissues. For example, hematopoietic stem cells derived from bone marrow give rise to various blood cells. 65 Skeletal muscle satellite cells, derived from striated muscle, may be HUNTER ET AL. capable of giving rise to muscle, bone, or adipose tissue. 66, 67 Mesenchymal stem cells derived from various connective tissues can give rise to muscle, bone, cartilage, ligament, tendon, and adipose tissues. [68] [69] [70] [71] Given the function of the notochordal cell in forming the spinal column, perhaps they represent a stem cell for the nucleus pulposus.
Although stem cells have received the most attention in the lay press, there are other cell roles during organogenesis that could be tapped for tissue regeneration. One such role is the organizer cells, which coordinates the behavior of other cell types in the growing embryo. [72] [73] [74] [75] The classic example of an organizer was first described by Spemann and Mangold, 75 who demonstrated that a region of the embryo was capable of inducing formation of the vertebrate nervous system. Although the concept of an organizer has remained largely a subject for developmental neurobiology, it seems possible that similar behaviors could exist in other embryonic tissues. As outlined earlier, the notochord influences formation of several embryonic tissues, and may have a similar function during formation of the intervertebral disk. In this case, the notochordal cells may help recruit and coordinate other mesenchymal cells to synthesize the nucleus pulposus. If so, the notochordal cells may be able to play the same role in a damaged or diseased disk. Cells-either from the damaged tissue or delivered along with the notochordal cells-could be directed to recapitulate part of embryonic development, synthesizing a new nucleus to replace the damaged tissue.
POTENTIAL APPLICATIONS IN TISSUE ENGINEERING
The intervertebral disk has only more recently become the subject of tissue-engineering studies. This is probably due in part to the complicated structure and mechanical environment of the disk, yet advances in tissue engineering of articular cartilage and fibrocartilage are encouraging enough to begin developing a tissue-engineered IVD treatment. Okuma et al. and Nomura et al. demonstrated that allografting nucleus pulposus material in rabbits retarded degeneration of the disk, suggesting that tissue-engineered nuclear implants may be capable of altering the pathogenesis of disk disease. 76, 77 Sun et al. demonstrated promising results in vitro by growing cells isolated from the nucleus pulposus on collagen IIcoated culture well inserts. After 10 weeks in culture, the resulting engineered tissues contained DNA, sulfated glycosaminoglycan (sGAG), and hydroxyproline densities comparable to those in native tissue. 78 In preliminary work, Mizuno et al. attempted to simultaneously tissue engineer both the nucleus pulposus and the anulus fibrosus, using cells seeded into alginate and polyglycolic acid (PGA) felt, respectively. After 16 weeks in vitro, the engineered tissues approximated the native tissue in sGAG, DNA, and hydroxyproline content, but the compressive stiffness was still lower than that of native tissue. 79 It has been shown that notochordal cells can function both to synthesize new extracellular matrix material 63 and to regulate proteoglycan synthesis by other nuclear cells. 64 Notochordal cells may be a powerful tool for tissue engineering of the nucleus pulposus, either as a primary source of stem cells or as an "organizer" cell to direct the function of other cells. By synthesizing new matrix material (either directly or indirectly), they could be used to reconstruct damaged or diseased tissue. Given the typical functions of some of the proteins discussed earlier (galectin 3, CD44s, and collagen IIA), it seems possible that the notochordal cell acts at least in part to coordinate and direct the function of other cells. Restoring the notochordal population in a degenerate disk might therefore act to recruit other cells to synthesize new matrix material. The body's own differentiated cells might recapitulate part of embryonic development, rebuilding the damaged disk.
Some authors have hypothesized that much of the infirmity associated with advancing age is due in part to the gradual loss of stem cells that can replenish differentiated cell populations and repair damage. 69, [80] [81] [82] Whether the notochordal cell is a stem cell or an organizer cell, a similar hypothesis can be put forth for the nucleus pulposus. As notochordal cells are typically lost during aging, the remaining cells may be insufficient in number or organization to maintain or repair the nucleus-particularly in light of the lean nutritional supply in the avascular adult nucleus pulposus. This would leave the cells unable to compensate for accumulated damage to the disk, and may be an initiating event in disk degeneration. Therefore restoring the notochordal cell population may help to slow or reverse damage to the adult disk.
If the notochordal cell is an "organizer" in disk formation and repair, it may be possible to identify the relevant signals used to direct the process. Therefore one could avoid the need to implant notochordal cells, and instead inject a cocktail of appropriate soluble cell signaling factors. The disk cells could then be stimulated to form a repair without the potential complications of producing and delivering a therapeutic population of notochordal cells. In this case, tissue-engineering research would produce a pharmacotherapy rather than an implantable engineered tissue.
THE FIRST QUESTION IN THE CONTEXT OF TISSUE ENGINEERING
The first and most urgent question is whether residual adult notochordal cells are stem cells or organizer cells.
NOTOCHORDAL CELL IN NUCLEUS PULPOSUS
The answer to this question will have a dramatic impact on how the therapeutic applications of notochordal cells are explored.
To test this question, we might start by defining a "stem cell" as opposed to other cell types. One useful definition is thus:
1. [The stem cell] is not itself terminally differentiated (i.e., it is not at the end of a pathway of differentiation). 2. It can divide without limit (or at least for the lifetime of the animal). 3. When it divides, each daughter has a choice: it can either remain a stem cell, or it can embark on a course leading irreversibly to terminal differentiation. 83 This definition could be used to determine whether notochordal cells are stem cells. First, the cells must not be terminally differentiated. This would mean that they are capable of transforming into at least one other distinct cell type, such as a mature nucleus pulposus chondrocyte as already suggested by some authors. 30, 32, 63 Second, they must be indefinitely expandable. This would mean that locating sufficient quantities of cells in vivo would be a relatively minor issue; a tiny number of cells isolated from one individual could be expanded in culture to treat hundreds of immune-matched or immunoprotected patients. Third, they must have the ability to simultaneously self-renew and differentiate. This would mean that a population of stem cells could remain in the treated tissues, standing by to respond to future disease or injury. (Clearly application of stem cell therapies would also benefit from an understanding of why the individual's original stem cells were no longer available to conduct a repair. If the factors that caused the loss of the original population were still present, the implanted cells may do little good to the patient. Likewise, a preemptive approach that prevented loss of the original stem cells might delay or prevent onset of degeneration.) If it turns out that the notochordal cells are not stem cells and are not indefinitely expandable, how can we isolate sufficient numbers of notochordal cells for therapeutic purposes? If the notochordal cells function to directly synthesize new matrix, a relatively large number of cells may be necessary, whereas if the cells function as organizers to direct synthesis by other cells, a relatively small number will likely be needed. As mentioned previously, the notochordal cells disappear after approximately age 10 years in humans, making cell sourcing a real concern. There are several options that may become available in the future. The simplest is collection of cadaveric cells (which is currently being done to generate cell banks for tissue-engineered cartilage). Nuclear material could be collected from young tissue donors and notochordal cells collected from the disks. More unusual, but theoretically possible, tissue sources include trans-genic animal donors. Cells could be harvested from animals-for example, pigs-which had been genetically engineered to express human antigens. As the nucleus is an avascular tissue, the chances of immune complications are already small, and tissue rejection may not be a significant issue.
CHORDOMA-THE RETURNING NOTOCHORD?
There is another related issue that may lend insight into the question of where to obtain notochordal cells. Chordoma is a rare malignant tumor that occurs primarily in older adults, reaching peak incidence after age 50 years. The tumor forms in the spinal column, with approximately one-half of the cases occurring in the sacrococcygeal region, one-third at the base of the skull, and the remaining cases generally in the transverse processes of the vertebrae. [84] [85] [86] The prevailing theory is that these tumors arise from residual notochord tissue; this despite another prevailing theory that notochord tissue disappears by age 10 years. To date, few studies have definitively observed normal notochord tissue in adult humans. Obviously there is a discrepancy here that deserves some attention. Two possible solutions exist to this conflict. Chordoma cells might not be of notochord origin, but they begin to express genes and proteins typical of notochordal cells as they transform. Alternatively, chordoma cells might indeed derive from residual notochord, and this tissue simply has not been found yet. Application of Occam's Razor suggests that the simpler answerthat notochordal cells do reside in the adult spine, but have not been observed yet-is the true one. Only further study will solve this dilemma. Perhaps a potent cell for spinal therapy lies within each of us, waiting to be discovered.
CONCLUSION
The vertebrate notochord is essential for formation of the nervous system and spinal column, and may play an important role in development of the intervertebral disk. If residual notochordal cells exist in the human spine, they may represent a powerful resource for tissue-engineered repairs of the degenerate nucleus pulposus and intervertebral disk. There is a need for further research to determine how often these cells are retained in the human, whether they are stem cells or organizer cells, and how best to use them to conduct in vivo disk repairs. The preliminary results are intriguing, and future efforts may reveal whether these cells have the potential to treat one of the most widespread musculoskeletal problems in the industrialized world.
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